We are live on ! Find out more
CG

Column Group Portfolio holdings

AUM $88.1M
1-Year Est. Return 148.03%
This Fund
S&P 500
This Quarter Est. Return
+12.28%
1 Year Est. Return
+148.03%
3 Year Est. Return
+95.12%
5 Year Est. Return
+23.89%
10 Year Est. Return
AUM
$69.6M
AUM Growth
-$1.7M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
6
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ORIC icon
1
Oric Pharmaceuticals
ORIC
$1.44B
$36.3M 52.16%
3,540,777
TNYA icon
2
Tenaya Therapeutics
TNYA
$163M
$18.1M 26.08%
9,400,290
SRZN icon
3
Surrozen
SRZN
$282M
$9.7M 13.95%
810,088
RAPT
4
DELISTED
RAPT Therapeutics
RAPT
$5.39M 7.74%
335,078
SGMT icon
5
Sagimet Biosciences
SGMT
$656M
$47.6K 0.07%
17,169
RVMD icon
6
Revolution Medicines
RVMD
$43.7B
$2.09K ﹤0.01%
46

Similar funds

Column Group's Q3 2024 Portfolio in Review

As of Q3 2024, Column Group held 6 positions worth $69.6M, down 2.4% from $71.3M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q3 2024: portfolio turnover was 0%. Column Group opened no new positions and made no exits, leaving the 6-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Column Group's ten largest holdings make up 100% of its $69.6M portfolio in Q3 2024.
  • Column Group opened 0 new positions and closed 0 in Q3 2024.
  • Column Group's portfolio value fell 2.4% quarter-over-quarter to $69.6M.

Based on Column Group's 13F filing for Q3 2024, filed 14 Nov 2024.